Showing results (201-210 of 255) with videos related to
Sort By:
Pageof 26
The Journal of Biological Chemistry|November 25, 1989
Structure of the gene for human von Willebrand factorD J Mancuso, E A Tuley, L A Westfield, et al.Biorxiv : the Preprint Server for Biology|September 15, 2025
Life-long hydroxyurea treatment decreases chronic pain in sickle cell disease miceNyabouk J Gayluak, Sourav S Roy, Ashley N Plumb, et al.Biorxiv : the Preprint Server for Biology|October 3, 2025
Peripheral nerve-targeting and pain-promoting transcriptomic signatures in early Guillain-Barré syndromeJayden A O'Brien, Joseph B Lesnak, Ishwarya Sankaranarayanan, et al.BMC Public Health|November 5, 2010
Testing for sexually transmitted infections in general practice: cross-sectional studyKatharine E Sadler, Nicola Low, Catherine H Mercer, et al.Biorxiv : the Preprint Server for Biology|May 10, 2023
Gut microbiota and metabolites drive chronic sickle cell disease painKatelyn E Sadler, Samantha N Atkinson, Vanessa L Ehlers, et al.Biorxiv : the Preprint Server for Biology|January 3, 2024
Keratinocyte Piezo1 drives paclitaxel-induced mechanical hypersensitivityAlexander R Mikesell, Elena Isaeva, Marie L Schulte, et al.Journal of Thrombosis and Haemostasis : JTH|June 26, 2016
Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC MiamiT Obser, M Ledford-Kraemer, F Oyen, et al.Science Translational Medicine|December 11, 2024
Increased keratinocyte activity and PIEZO1 signaling contribute to paclitaxel-induced mechanical hypersensitivityAlexander R Mikesell, Elena Isaeva, Marie L Schulte, et al.Blood|February 1, 1990
Severe type III von Willebrand's disease caused by deletion of exon 42 of the von Willebrand factor gene: family studies that identify carriers of the condition and a compound heterozygous individualI R Peake, M B Liddell, P Moodie, et al.AIDS (London, England)|May 1, 1992
Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatmentB J Brew, R B Bhalla, M Paul, et al.Pageof 26